Author/Creator: Arnall, Justin R - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Arnall, Justin R

1. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice. (January 2019)

Authors:: Arnall, Justin R; Petro, Robin; Patel, Jai N; Kennedy, LeAnne
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 25:Number 1(2019)
Page Start:: 179
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Caplacizumab: an anti–von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura. (26th June 2020)

Authors:: Hollifield, Alyssa L; Arnall, Justin R; Moore, Donald C
Journal:: American journal of health-system pharmacy
Issue:: Volume 77:Number 15(2020)
Page Start:: 1201
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement. (June 2019)

Authors:: Arnall, Justin R; Usmani, Saad Z; Adamu, Hawawu; Mishkin, Joseph; Bhutani, Manisha
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 25:Number 4(2019)
Page Start:: 1021
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report. (September 2019)

Authors:: Hartsell, Lauren; Janes, Amanda; Larck, Chris; Park, Steven; Arnall, Justin R
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 25:Number 6(2019)
Page Start:: 1534
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia. (July 2021)

Authors:: DiSogra, Kristyn Y; Tran, Thuy; Arnall, Justin R; Janes, Amanda; Moore, Donald C; Park, Steven I
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 27:Number 5(2021)
Page Start:: 1265
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. (April 2019)

Authors:: Moore, Donald C; Arnall, Justin R; Harvey, R Donald
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 25:Number 3(2019)
Page Start:: 613
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Measuring the Impact of a Pharmacist-Driven Blood Factor Education Program: A Prospective, Single-Center Observational Study. (June 2023)

Authors:: Arnall, Justin R; Moore, Donald C; Michael, Meghan; Wolcott, Michael; Cowgill, Nicole
Journal:: Hospital pharmacy
Issue:: Volume 58:Number 3(2023)
Page Start:: 282
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Necessity of pharmacist-driven nonprescription telehealth consult services in the era of COVID-19. (14th May 2020)

Authors:: Yemm, Kristyn E; Arnall, Justin R; Cowgill, Nicole A
Journal:: American journal of health-system pharmacy
Issue:: Volume 77:Number 15(2020)
Page Start:: 1188
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Publication rates of hematology/oncology abstracts presented at major pharmacy association meetings. (April 2022)

Authors:: Wooten, Kiley M; Arnall, Justin R; Bowser, Kiarra M; J Pennell, Laurie; Wade-Davis, Jazmin N; Olin, Jacqueline L; Taylor, Margaret; Moore, Donald C
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 28:Number 3(2022)
Page Start:: 582
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗